GenSci

🥳The clinical trial Commencement of GenSci098 injection has been approved by the NMPA. GenSci098 injection is indicated for the treatment of #Thyroid Eye Disease. This IND approval marks the active exploration unleashing innovative capabilities of GenSci to develop high-potential R&D pipelines and enrich the portfolio in diverse fields. Learn more information about GenSci: https://lnkd.in/gzb5vHxe #GenSci# # #NMPA# #research

The "Zhejiang University - GenSci Joint Research Center of Children’s Health" was recently established. Focusing on children's health management from screening to recovery, the center concentrates on research and therapeutic development for major, urgent, severe, and rare pediatric diseases. This approach will accelerate clinical translation, foster the development of innovative technologies, cultivate talents, and build robust disciplines. For more information: https://lnkd.in/gUR-MMAU #GenSci #ZhejiangUniversity #Childhealth #hospital #cooperation #clinical #pharmaceutical 

NMPA: New Drug Application of Recombinant Human Follicle-Stimulating Hormone - CTP Fusion Protein Injection Accepted 😀 Read more about this: https://lnkd.in/g_aEfww8 #GenSci #womenshealth #assistedreproductivetherapy #ART #Gynecology

R&D Innovation Accelerator: Shanghai Children's Hospital and GenSci Ink Strategic Cooperation Agreement Great news! GenSci signed a strategic cooperation agreement with Shanghai Children's Hospital. Under the agreement, the two sides will collaboratively set up a research and development (R&D) center. This initiative is designed to facilitate the exchange of scientific research and to hasten the translation of scientific and technological breakthroughs into commercial applications. Mr. Lu Bing, Director of Shanghai Children's Hospital, and Mr. Jin Lei, General Manager of GenSci, signed the agreement. Get to know more: https://lnkd.in/gKqKpzAg #GenSci #ShanghaiChildren'sHospital #pediatric #childrenshealth

GenSci is pleased to announce our participation in the CPHI South East Asia 2024 exhibition in Bangkok, Thailand. The CPHI South East Asia 2024 is a pivotal event in the ASEAN pharmaceutical industry. We cordially invite professionals and partners to visit us and explore collaboration opportunities at Booth H23 from July 10 to 12, 2024, where we will share our latest innovations and flagship products. For more information: https://lnkd.in/gFUqtUwd #GenSci #Growthforlife #CPHISEA2024 #ASEAN #pharmaceutical #Thailand

Cheers! 🤗  A further step towards GenSci’s vision of becoming a global leader in Pediatric and Women's Health! GenSci recently announced that its Jin Sai Xin® progesterone injection (II) (hereafter referred to as Jin Sai Xin), has received approval from the National Medical Products Administration (NMPA) of China. This approval is for the supplementary treatment of progesterone in assisted reproductive technology (ART), catering specifically to women who are unable to use or do not tolerate vaginal formulations. As China's first aqueous solution progesterone injection, Jin Sai Xin is bioequivalent to its original drug counterparts. Research confirms that the subcutaneous injection method it utilizes is proven to minimize the risk of adverse reactions, significantly streamline the treatment process, and lower additional costs, while also enhancing patient compliance. Get to know more: https://lnkd.in/gREyJB_X #GenSci #JinSaiXin #Womenshealth #research #assistedreproductive #Fertility

🤗 📣 Bravo! GenSci Singapore and @TWi Pharmaceuticals, Inc. (TWi), a leading pharmaceutical company, have recently reached a cooperation agreement for the exclusive distribution of Megaxia® (megestrol acetate oral suspension). Under this agreement, TWi authorizes GenSci Singapore as the sole distributor of Megaxia® in mainland China, Hong Kong, Macau, and Singapore, responsible for the marketing and promotion of this product. To learn more about this great news: https://lnkd.in/eJyc9Ciz #GenSci #Oncology #Megaxia #Growthforlife

The average human lifespan is estimated to span 26,791 days. Women, on average, surpass this benchmark by living 27,083 days, in contrast to men who live an average of 25,477 days. This disparity indicates that women typically outlive men by approximately 1,606 days. However, it is noteworthy that women experience a 25% greater duration of time in suboptimal health conditions compared to men. Discover the latest research insights in the field of health: https://lnkd.in/gwmDdhCc Despite these statistics, there are specific periods in a woman's life where she exhibits enhanced resilience to health challenges. These pivotal moments are crucial for maintaining and promoting women's overall health and well-being. GenSci, recognized for its extensive experience and profound expertise in the domain of women's health, takes a holistic approach to health management. By acknowledging the unique biological and reproductive characteristics of women, we offer a comprehensive suite of health services designed to safeguard their well-being. Our commitment extends across the spectrum of women's health needs, from assisted reproduction and menopausal support to the management of common gynecological conditions. Learn more about our organization and our dedication to women's health excellence: https://lnkd.in/g8NA54Qn Tim Rudolphi #GenSci #Womenhealth #healthgap

GenSci is honored to announce our participation at Booth W4E59 from June 19 to 21, 2024, at CPhI China 2024 in Shanghai. 😊 CPhI China 2024, Asia's premier pharma event, is the perfect setting for GenSci to connect with industry leaders and forge new partnerships. We are eager to share our vision and collaborate on groundbreaking projects that will contribute to a healthier world. See you there! https://lnkd.in/gUhH8aui #GenSci #CPhI #Pharma #Growthforlife #biology #biotech

🌟 Celebrating Children's Day with GenSci 🌟 Today, we celebrate the boundless potential and innocence of children. GenSci is dedicated to nurturing their growth and supporting their dreams. Grow with Us: As the world's exclusive provider of recombinant human growth hormone products, we are committed to helping children reach their full potential, both in stature and in life. Dream Bigger: On this Children's Day, we invite you to join us in our mission. Together, we will innovate to not only safeguard the health of children but also to empower them to dream without limits. 👨👩👧👦 Happy Children's Day from GenSci! May this day be a stepping stone to a future filled with joy, laughter, and the promise of a brighter, healthier tomorrow. #ChildrensDay #GenSci #HealthcareInnovation #GlobalHealth #PediatricHealth #HealthcareSolutions #RecombinantHumanGrowthHormone